Navigation Links
Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
Date:10/19/2010

MOUNTAIN VIEW, Calif., Oct. 19 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has reacquired the U.S. and Canadian rights for AZ-004 (Staccato® loxapine) from Biovail Laboratories International SRL ("BLS"), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE and TSX: VRX) ("Valeant").  AZ-004 is being developed for the rapid treatment of agitation in schizophrenia or bipolar disorder patients.  Alexza previously established a collaboration arrangement with BLS, to develop and commercialize AZ-004 in the U.S. and Canada, for which Alexza received a $40 million upfront payment.  On September 28, 2010, Biovail Corporation and Valeant Pharmaceuticals International completed their merger.  As part of the review of the merged company's commercial and development pipelines, BLS has decided not to continue the AZ-004 project pursuant to the terms of the agreements between BLS and Alexza.  Based on the comprehensive clinical development program conducted for AZ-004 and the significant unmet medical need for patients, physicians and caregivers, Alexza intends to seek one or more pharmaceutical partners for the worldwide development and commercialization of AZ-004.

"The transaction with BLS has been of great value in allowing us to advance the development of AZ-004 and to expand our understanding of the market opportunity for this novel therapeutic," said Thomas B. King, Alexza President and CEO.  "While we would have been pleased to continue what has been a great working relationship with BLS, we understand BLS' strategic interest in focusing on its core therapeutic areas.  We look forward to advancing the development of AZ-004 and will provide further details regarding this program after we have our follow-on meeting with the FDA."

Under the terms of the agreements, with this
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Diseases largely eradicated in ... are returning. Measles was declared eliminated in 2000, yet ... of August 15—the highest incidence in 20 years. In ... declared whooping cough a problem of "epidemic proportions." ... and dying from these preventable diseases—in part because some ...
(Date:8/29/2014)... 29, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... Chief Executive Officer, will present at the CL King ... Tuesday, September 9, 2014 at 12:30 p.m. ET. The ... Hotel in New York City . ...
(Date:8/29/2014)... -- , Industry professionals and media ... taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of #CPhIChat ... its kind global industry-wide Tweetchat for pharma professionals ... to stimulate conversations on key industry issues and ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... the three months ended September 30, 2011 (Fiscal Year ... Following the commencement of initial supplies of ... progressively increased production capacities at its York, PA facility. ...
... Calif., Nov. 9, 2011 diaDexus, Inc. (OTC Bulletin Board: ... development and commercialization of patent-protected in vitro diagnostic ... results for the third quarter of 2011. Total ... million, representing 38% growth over total revenues of $3.2 million ...
Cached Medicine Technology:Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 2Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 3Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 4Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 5Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 6Unilife Corporation Announces Financial Results for Fiscal Year 2012 First Quarter 7diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 2diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 3diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 4diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 5diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter 6
(Date:8/31/2014)... 31, 2014 Just in time for Washington’s ... only wild, sustainable Alaska Salmon, award winning chowder ... Duke's Green Lake location , Sunday, September 28, 2014 ... sample several ethnic salmon BBQ culinary delights. Live music will ... from Hawaii, Puerto Rico and Mexico will be featured. ...
(Date:8/31/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... of bamboo veneers . Additionally, it has deiced offer ... high quality products. The promotion will last from today until ... its top quality veneers are hot in the global market. ... bamboo veneers. All these items are made according to our ...
(Date:8/31/2014)... Mesa, AZ (PRWEB) August 31, 2014 ... in Mesa, Arizona, prescribes sublingual immunotherapy to help his ... includes tree nut allergies. Dr. Agren said that it ... nut-based foods and, in many cases, restored peace of ... can lead to a host of symptoms, including rashes, ...
(Date:8/31/2014)... With years of hard work, Delta has now ... machines. Recently, the company has updated its wheel loader ... loaders. All these items are guaranteed to be great. Additionally, ... , It is true that all items in Delta’s ... machine specialists. The firm is making full efforts to help ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 1Heart Caregiver ... Clarito and brain fitness expert Tee Barr conducted a ... Ventura City. Activities Director Virginia Ayala and Social Services ... and patients attend this brain fitness session. , Research ... and slowing down the development of dementia and memory ...
Breaking Medicine News(10 mins):Health News:Seattle Seafood Restaurant Duke's Chowder House on Green Lake Will Celebrate The Long Anticipated Indian Summer With First Annual Sizzling BBQ Salmon Tasting Event. 2Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 3Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 3Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 4
... Georgia Tech Research Institute (GTRI) have developed a sensor ... to asthma attacks. Worn in the pockets of a ... causes of asthma attacks. , We are investigating whether ... see what was going on environmentally when the attack ...
... The use of regular, long-term aspirin and non-steroidal ... cancer, according to a study published in Gastroenterology ... (AGA) Institute. However, the use of aspirin for chemoprevention ... doses that are higher than recommended over a long ...
... prescription drugs so that the system more closely resembles ... drug use without altering patients out-of-pocket spending, health plan ... RAND Corporation study. , Researchers propose that consumers pay ... a years worth of medicine for each prescription they ...
... need to be monitored closely, study says , , TUESDAY, Jan. ... of patients with kidney or liver cancer also increases the ... Nexavar (sorafenib) need to be carefully monitored and treated, said ... online issue of Lancet Oncology . , Nexavar is ...
... Medicine (IGM) at Johns Hopkins will join other national ... ambitious effort that will involve sequencing the genomes of ... most detailed and medically useful picture to date of ... in creating a map of common DNA variation in ...
... Same-sex couples are just as committed in their ... have studied the quality of adult relationships and ... couples in same-sex relationships are not as committed ... as psychologically healthy. , These results are from ...
Cached Medicine News:Health News:Investigating causes of asthma attacks: New sensor system monitors environmental exposure 2Health News:Regular, long-term aspirin use reduces risk of colorectal cancer 2Health News:Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions 2Health News:Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions 3Health News:Liver Cancer Drug Raises Blood Pressure 2Health News:Johns Hopkins to participate in 1000 Genomes Project 2Health News:Equal level of commitment and relationship satisfaction found among gay and heterosexual couples 2Health News:Equal level of commitment and relationship satisfaction found among gay and heterosexual couples 3
... Central Blood Pressure/Pulse Wave Velocity System is an ... system enables the measurement of the velocity of ... The velocity of the pressure wave along the ... artery. This system is most commonly used to ...
Used to remove wrinkles from sections and for reorientating embedded tissue....
Liquichek Blood Gas Plus CO-Oximeter Control (Radiometer) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximeter (Radiometer) ...
Liquichek Blood Gas Plus E Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2 and electrolytes. Available in four levels....
Medicine Products: